DELUXE CORPORATION Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
DELUXE CORPORATION (DLX) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-26.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2019-02-26
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-12-31 was $0.00.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2016 was $0.00.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2015 was $0.00.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was -$589.00K, a 683.17% decline from fiscal 2013.
- DELUXE CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2013 was $101.00K.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $0.00 derived: sum of 2 quarters · filed 2018-02-23 | $0.00 derived: sum of 3 quarters · filed 2018-02-23 | $0.00 10-K · filed 2018-02-23 |
| 2015-09-30 | $0.00 10-Q · filed 2015-10-27 | $0.00 derived: sum of 2 quarters · filed 2015-10-27 | $0.00 10-Q · filed 2015-10-27 | -$739.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $0.00 10-Q · filed 2015-07-27 | $0.00 10-Q · filed 2015-07-27 | -$739.00K derived: sum of 3 quarters · filed 2017-02-24 | -$697.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-01 | -$739.00K derived: sum of 2 quarters · filed 2017-02-24 | -$697.00K derived: sum of 3 quarters · filed 2017-02-24 | -$640.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | -$739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$697.00K derived: sum of 2 quarters · filed 2017-02-24 | -$640.00K derived: sum of 3 quarters · filed 2017-02-24 | -$589.00K 10-K · filed 2017-02-24 |
| 2014-09-30 | $42.00K 10-Q · filed 2015-10-27 | $99.00K derived: sum of 2 quarters · filed 2015-10-27 | $150.00K 10-Q · filed 2015-10-27 | $180.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $57.00K 10-Q · filed 2015-07-27 | $107.00K 10-Q · filed 2015-07-27 | $138.00K derived: sum of 3 quarters · filed 2016-02-19 | $126.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $50.00K 10-Q · filed 2015-05-01 | $81.00K derived: sum of 2 quarters · filed 2016-02-19 | $69.00K derived: sum of 3 quarters · filed 2016-02-19 | $113.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $19.00K derived: sum of 2 quarters · filed 2016-02-19 | $63.00K derived: sum of 3 quarters · filed 2016-02-19 | $101.00K 10-K · filed 2016-02-19 |
| 2013-09-30 | -$12.00K 10-Q · filed 2014-10-30 | $32.00K derived: sum of 2 quarters · filed 2014-10-30 | $70.00K 10-Q · filed 2014-10-30 | -$421.00K derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | $44.00K 10-Q · filed 2014-08-01 | $83.00K 10-Q · filed 2014-08-01 | -$409.00K derived: sum of 3 quarters · filed 2015-02-20 | -$938.00K derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $38.00K 10-Q · filed 2014-05-01 | -$453.00K derived: sum of 2 quarters · filed 2015-02-20 | -$982.00K derived: sum of 3 quarters · filed 2015-02-20 | -$948.00K derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | -$491.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | -$1.02M derived: sum of 2 quarters · filed 2015-02-20 | -$986.00K derived: sum of 3 quarters · filed 2015-02-20 | -$1.23M 10-K · filed 2015-02-20 |
| 2012-09-30 | -$529.00K 10-Q · filed 2013-10-30 | -$495.00K derived: sum of 2 quarters · filed 2013-10-30 | -$735.00K 10-Q · filed 2013-10-30 | -$193.00K derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $34.00K 10-Q · filed 2013-07-31 | -$206.00K 10-Q · filed 2013-07-31 | $336.00K derived: sum of 3 quarters · filed 2014-02-28 | $410.00K derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | -$46.00K 10-Q · filed 2013-05-02 | $302.00K derived: sum of 2 quarters · filed 2014-02-28 | $376.00K derived: sum of 3 quarters · filed 2014-02-28 | $219.00K derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $422.00K derived: sum of 2 quarters · filed 2014-02-28 | $265.00K derived: sum of 3 quarters · filed 2014-02-28 | -$175.00K 10-K · filed 2014-02-28 |
| 2011-09-30 | $74.00K 10-Q · filed 2012-10-31 | -$83.00K derived: sum of 2 quarters · filed 2012-10-31 | -$523.00K 10-Q · filed 2012-10-31 | -$498.00K derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | -$157.00K 10-Q · filed 2012-08-03 | -$597.00K 10-Q · filed 2012-08-03 | -$572.00K derived: sum of 3 quarters · filed 2013-02-22 | -$447.00K derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | -$439.00K 10-Q · filed 2012-05-04 | -$415.00K derived: sum of 2 quarters · filed 2013-02-22 | -$290.00K derived: sum of 3 quarters · filed 2013-02-22 | -$138.00K derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | $24.00K derived: 10-K 12 month − 8-K 9 month · filed 2013-02-22 | $149.00K derived: sum of 2 quarters · filed 2013-02-22 | $301.00K derived: sum of 3 quarters · filed 2013-02-22 | $475.00K 10-K · filed 2013-02-22 |
| 2010-09-30 | $125.00K 8-K · filed 2011-11-22 | $277.00K derived: sum of 2 quarters · filed 2011-11-22 | $451.00K 8-K · filed 2011-11-22 | |
| 2010-06-30 | $152.00K 10-Q · filed 2011-08-08 | $326.00K 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $102.00K 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCO BRANDS Corp (ACCO) | United States | $0.398B | 6.53 |